Our familiarity with the standardized pharmaceutical data sets coupled with our expertise in econometric analysis sets us apart in our ability to bring large quantities of data to bear on issues of market definition and other relevant issues. We have testified before the U.S. Congress and in court on reverse payment patent settlements, as well as authored seminal articles on the subject. In addition, we have been involved in a series of litigations over pricing and reimbursement benefits involving average wholesale price (AWP).

Compass Lexecon economists can assist pharmaceutical industry clients with any aspect of a case, including: